Overview of VZV associated Cell line (Mutation)

ID Literature Title Group
1 25712361 Drug resistance of clinical varicella-zoster virus strains confirmed by recombinant thymidine kinase expression and by targeted resistance mutagenesis of a cloned wild-type isolate
Mutation
2 21345964 Mutagenesis of varicella-zoster virus glycoprotein I (gI) identifies a cysteine residue critical for gE/gI heterodimer formation, gI structure, and virulence in skin cells
Mutation
3 16971426 ORF66 protein kinase function is required for T-cell tropism of varicella-zoster virus in vivo
Mutation
4 38042814 Targeted mutagenesis of the herpesvirus fusogen central helix captures transition states
Mutation
5 15194755 Complete DNA sequence analyses of the first two varicella-zoster virus glycoprotein E (D150N) mutant viruses found in North America: evolution of genotypes with an accelerated cell spread phenotype
Mutation
6 18495764 Varicella-zoster virus open reading frame 66 protein kinase is required for efficient viral growth in primary human corneal stromal fibroblast cells
Mutation
7 15507627 Functions of the C-terminal domain of varicella-zoster virus glycoprotein E in viral replication in vitro and skin and T-cell tropism in vivo
Mutation
8 20106918 Characterization of the varicella-zoster virus ORF50 gene, which encodes glycoprotein M
Mutation
9 27795423 Dysregulated Glycoprotein B-Mediated Cell-Cell Fusion Disrupts Varicella-Zoster Virus and Host Gene Transcription during Infection
Mutation
10 14581575 Requirement of varicella-zoster virus immediate-early 4 protein for viral replication
Mutation
11 26914506 Mutational analysis of varicella-zoster virus (VZV) immediate early protein (IE62) subdomains and their importance in viral replication
Mutation
12 29858833 Analysis of IE62 mutations found in Varicella-Zoster virus vaccine strains for transactivation activity
Mutation
13 24874654 The cytoplasmic domain of varicella-zoster virus glycoprotein H regulates syncytia formation and skin pathogenesis
Mutation
14 33411789 The N-terminus of varicella-zoster virus glycoprotein B has a functional role in fusion
Mutation
15 39569446 Single Amino Acid Substitution Within the Helicase of Varicella Zoster Virus Makes It Resistant to Amenamevir
Mutation
16 39385182 Upregulation of keratin 15 is required for varicella-zoster virus replication in keratinocytes and is attenuated in the live attenuated vOka vaccine strain
Mutation
17 30728261 Comparison of the Whole-Genome Sequence of an Oka Varicella Vaccine from China with Other Oka Vaccine Strains Reveals Sites Putatively Critical for Vaccine Efficacy
Mutation
18 1848597 Analysis of mutations in the thymidine kinase genes of drug-resistant varicella-zoster virus populations using the polymerase chain reaction
Mutation
19 1658351 Mutant varicella-zoster virus thymidine kinase: correlation of clinical resistance and enzyme impairment
Mutation
20 22190713 In vitro-selected drug-resistant varicella-zoster virus mutants in the thymidine kinase and DNA polymerase genes yield novel phenotype-genotype associations and highlight differences between antiherpesvirus drugs
Mutation
21 23269791 ORF9p phosphorylation by ORF47p is crucial for the formation and egress of varicella-zoster virus viral particles
Mutation
22 23322733 An immunoreceptor tyrosine-based inhibition motif in varicella-zoster virus glycoprotein B regulates cell fusion and skin pathogenesis
Mutation
23 23966396 Varicella-zoster virus open reading frame 48 encodes an active nuclease
Mutation
24 19474103 Mutagenesis of varicella-zoster virus glycoprotein B: putative fusion loop residues are essential for viral replication, and the furin cleavage motif contributes to pathogenesis in skin tissue in vivo
Mutation
Contents
Description
Disease Group Note
  • The label in Group indicates that the disease is mentioned in mutation or integration research. Click the eye label to view the corresponding module information.